ANDREATA FRANCESCO

Sevieri, M., Andreata, F., Mainini, F., Signati, L., Piccotti, F., Truffi, M., et al. (2024). Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy. JOURNAL OF NANOBIOTECHNOLOGY, 22(1) [10.1186/s12951-024-02441-4]. Dettaglio

Kawashima, K., Andreata, F., Beccaria, C., Iannacone, M. (2024). Priming and Maintenance of Adaptive Immunity in the Liver. ANNUAL REVIEW OF IMMUNOLOGY, 42(1 (April 2024)), 375-399 [10.1146/annurev-immunol-090122-041354]. Dettaglio

Andreata, F., Moynihan, K., Fumagalli, V., Di Lucia, P., Pappas, D., Kawashima, K., et al. (2024). CD8 cis-targeted IL-2 drives potent antiviral activity against hepatitis B virus. SCIENCE TRANSLATIONAL MEDICINE, 16(729) [10.1126/scitranslmed.adi1572]. Dettaglio

Andreata, F., Clément, M., A Benson, R., Hadchouel, J., Procopio, E., Even, G., et al. (2023). CD31 signaling promotes the detachment at the uropod of extravasating neutrophils allowing their migration to sites of inflammation. ELIFE, 12, 1-24 [10.7554/eLife.84752]. Dettaglio

Iannacone, M., Andreata, F., Guidotti, L. (2022). Immunological insights in the treatment of chronic hepatitis B. CURRENT OPINION IN IMMUNOLOGY, 77(August 2022) [10.1016/j.coi.2022.102207]. Dettaglio